Antinociceptive effects of ONO-9902, an enkephalinase inhibitor, after visceral stress condition in rats

Canadian Journal of Anaesthesia

Volumn 43, Issue 11, 1996, Pages 1175-1179

  Yamamori, Yuji ^a   Saito, Yoji ^a   Kaneko, Megumi ^a   Kirihara, Yumiko ^a   Sakura, Shinichi ^a   Kosaka, Yoshihiro ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Analgesia, measurement, stress; Analgesics, enkephalinase inhibitor, ONO 9902; Pain, visceral, somatic

Indexed keywords

ENKEPHALINASE INHIBITOR; ONO 9902; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL STRESS; PRIORITY JOURNAL; RAT; VISCERAL PAIN;

EID: 0030498809     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03011848     Document Type: Article

References (22)

1. Chipkin RE. Inhibitors of enkephalinase: the next generation of analgesics. Drugs of the Future 1986; 11: 593-606.
2. Zhang A-Z, Yang H-YT, Costa E. Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors. Neuropharmacology 1982; 21: 625-30.
3. 5] enkephalin levels and release in rat spinal cord. Eur J Pharmacol 1989; 167: 367-73.
4. Chipkin RE, Berger JG, Billard W, Iorio LC, Chapman R, Barnett A. Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic. J Pharmacol Exp Ther 1988; 245: 829-38.
5. Oshita S, Yaksh TL, Chipkin R. The antinociceptive effects of intrathecally administered SCH 32615, an enkephalinase inhibitor in the rat. Brain Res 1990; 515: 143-8.
6. Al-Rodhan N, Chipkin R, Yaksh TL The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqeductal, ventral medulla and amygdala. Brain Res 1990; 520: 123-30.
7. Lecomte J-M, Costentin J, Vlaiculescu A, et al. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. J Pharmacol Exp Ther 1986; 237: 937-44.
8. Costentin J, Vlaiculescu A, Chaillet P, Natan LB, Aveaux D, Schwartz J-C. Dissociated effects of inhibitors enkephalin-metabolizing peptidases or naloxone on various nociceptive responses. Eur J Pharmacol 1986; 123: 37-44.
9. Yaksh TL. Opioid receptor systems and the endorphins : a review of their spinal organization. J Neurosurg 1987; 67: 157-76.
10. Jayaram A, Singh P, Carp HM. An enkephalinase inhibitor, SCH 32615, augments analgesia induced by surgery in mice. Anesthesiology 1995; 82: 1283-7.
11. Jayaram A, Singh P, Carp H. SCH 32615, an enkephalinase inhibitor, enhances pregnancy-induced analgesia in mice. Anesth Analg 1995; 80:944-8.
12. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res 1988; 450: 153-69.
13. Kaneko M, Saito Y, Kirihara Y, Collins JG, Kosaka Y. Synergistic antinociceptive interaction after epidural coadministration of morphine and lidocaine in rats. Anesthesiology 1994; 80: 137-50.
14. de Groat WC. Neuropeptides in pelvic afferent pathways. Experientia 1987; 43: 801-13.
15. DeLeo JA, Coombs DW, McCarthy LE. Differential c-fos-like protein expression in mechanically versus chemically induced visceral nociception. Molecular Brain Research 1991; 11: 167-70.
16. Cesselin F, Le Bars D, Bourgoin S, et al. Spontaneous and evoked release of methionine-enkephalin-like material from the rat spinal cord in vivo. Brain Res 1985; 339: 305-13.
17. Zhuo M, Gebhart GF. Inhibition of a cutaneous nociceptive reflex by a noxious visceral stimulus is mediated by spinal cholinergic and descending serotonergic systems in the rat. Brain Res 1992; 585 : 7-18.
18. Cadden SW, Morrison JFB. Effects of visceral distension on the activities of neurones receiving cutaneous inputs in the rat lumbar dorsal horn: comparison with effects of remote noxious somatic stimuli. Brain Res 1991; 558: 63-74.
19. Bodnar RJ, Kelly DD, Brutus M. Glusman M. Stress-induced analgesia: neural and hormonal determinants. Neurosci Biobehav Rev 1980; 4: 87-100.
20. Meynadier J, Dalmas S, Lecomte JM, Gros CI, Schwartz JC. Potent analgesic effects of inhibitors of enkephalin metabolism administered intrathecally to cancer patients. The Pain Clinic 1988; 2: 201-5.
21. Floras P, Bidabé A-M, Caillé J-M, Simonnet G, Lecomte J-M, Sabathié M. Double-blind study of effects of enkephalinase inhibitor on adverse reactions to myelography. Am J Neuroradiol 1983; 4: 653-5.
22. Wilier JC, Roby A, Ernst M. The enkephalinase inhibitor, GB 52, does not affect nociceptive flexion reflexes nor pain sensation in humans. Neuropharmacology 1986; 25: 819-22.